Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China
机构：[1]Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China[2]Department of Cardiac Function, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China内蒙古科技大学包头医学院[3]Department of Cardiology, Yuncheng Central Hospital, Yuncheng, Shanxi, China[4]Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China[5]Department of Cardiology, Chinese PLA General Hospital, Beijing, China[6]Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[7]Department of Cardiology, Tianjin Union Medical Center, Tianjin, China[8]Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, China[9]Department of Cardiology, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, China[10]Department of Cardiology, Jinzhou Central Hospital, Jinzhou, Liaoning, China[11]Department of Cardiology, Chifeng Municipal Hospital, Chifeng, Inner Mongolia, China[12]Department of Cardiology, Inner Mongolia People’s Hospital, Huhhot, China[13]Department of Cardiology, General Hospital of Ningxia Medical University, Yinchuan, China[14]Department of Cardiology, Liaoning Provincial People’s Hospital, Shenyang, China[15]Department of Cardiology, Jilin Central General Hospital, Jilin, China[16]Department of Cardiology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[17]Departments of Cardiology, Suzhou Kowloon Hospital, School of Medicine Shanghai Jiaotong University, Suzhou, Jiangsu, China[18]Department of Cardiology, Jingzhou Central Hospital, Jingzhou, Hubei, China[19]Department of Cardiology, Shanxi Provincial People’s Hospital, Taiyuan, China.
第一作者机构：[1]Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China
通讯作者：
推荐引用方式(GB/T 7714)：
Wang Zhen,Zhang Xin,Qu Yanling,et al.Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China[J].LIPIDS IN HEALTH AND DISEASE.2023,22(1):doi:10.1186/s12944-023-01838-8.
APA：
Wang Zhen,Zhang Xin,Qu Yanling,Zhang Shuyang,Chen Yundai...&Ge Junbo.(2023).Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China.LIPIDS IN HEALTH AND DISEASE,22,(1)
MLA：
Wang Zhen,et al."Icosapent ethyl therapy for very high triglyceride levels: a 12-week, multi-center, placebo-controlled, randomized, double-blinded, phase III clinical trial in China".LIPIDS IN HEALTH AND DISEASE 22..1(2023)
